AQST Historical PE Ratio image   This AQST PE ratio history page last updated 4/26/2024
AQST PE History Chart
PeriodPriceAdj. EPSTTMPE
Q4 2023
3/5/2024
4.19-0.10-0.12NA
Q3 2023
11/6/2023
1.63-0.03-0.25NA
Q2 2023
8/7/2023
2.05-0.10-0.45NA
Q1 2023
5/2/2023
1.390.11-0.71NA
Q4 2022
3/7/2023
0.85-0.23-1.14NA
Q3 2022
11/1/2022
0.86-0.23-1.29NA
Q2 2022
8/2/2022
0.88-0.36-1.43NA
Q1 2022
5/3/2022
1.37-0.32-1.40NA
Q4 2021
3/8/2022
2.82-0.38-1.49NA
Q3 2021
11/2/2021
5.36-0.37-1.71NA
Q2 2021
8/3/2021
3.25-0.33-1.83NA
Q1 2021
5/4/2021
3.65-0.41-1.57NA
Q4 2020
3/9/2021
4.47-0.60-1.65NA
Q3 2020
11/4/2020
5.28-0.49-1.53NA
Q2 2020
8/4/2020
5.49-0.07-1.58NA
Q1 2020
5/5/2020
4.50-0.49-2.33NA
Q4 2019
3/11/2020
2.94-0.48-2.43NA
Q3 2019
11/5/2019
4.23-0.54-2.51NA
Q2 2019
8/6/2019
3.15-0.82NANA
Q1 2019
5/8/2019
4.52-0.59NANA
Q4 2018
3/14/2019
6.37-0.56NANA
AQST Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q4 2023
3/5/2024
4.19-0.10-0.40NA
Q3 2023
11/6/2023
1.63-0.03-0.12NA
Q2 2023
8/7/2023
2.05-0.10-0.40NA
Q1 2023
5/2/2023
1.390.110.443.2
Q4 2022
3/7/2023
0.85-0.23-0.92NA
Q3 2022
11/1/2022
0.86-0.23-0.92NA
Q2 2022
8/2/2022
0.88-0.36-1.44NA
Q1 2022
5/3/2022
1.37-0.32-1.28NA
Q4 2021
3/8/2022
2.82-0.38-1.52NA
Q3 2021
11/2/2021
5.36-0.37-1.48NA
Q2 2021
8/3/2021
3.25-0.33-1.32NA
Q1 2021
5/4/2021
3.65-0.41-1.64NA
Q4 2020
3/9/2021
4.47-0.60-2.40NA
Q3 2020
11/4/2020
5.28-0.49-1.96NA
Q2 2020
8/4/2020
5.49-0.07-0.28NA
Q1 2020
5/5/2020
4.50-0.49-1.96NA
Q4 2019
3/11/2020
2.94-0.48-1.92NA
Q3 2019
11/5/2019
4.23-0.54-2.16NA
Q2 2019
8/6/2019
3.15-0.82-3.28NA
Q1 2019
5/8/2019
4.52-0.59-2.36NA
Q4 2018
3/14/2019
6.37-0.56-2.24NA
Quotes delayed 20 minutes

Email EnvelopeFree AQST Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aquestive Therapeutics (AQST) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ARAV PE Ratio History
ARAY PE Ratio History
ARCT PE Ratio History
ARDS PE Ratio History
ARDX PE Ratio History
ARNA PE Ratio History
ARPO PE Ratio History
ARQT PE Ratio History
ARTL PE Ratio History
ARVN PE Ratio History
On this page we presented the AQST PE Ratio History information for Aquestive Therapeutics' stock. The average AQST PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 3.2. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average AQST PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this AQST PE ratio history result, against the recent PE: when this page was posted on 4/25/2024, the most recent closing price for AQST had been 3.93, and the most recent quarterly earnings result, annualized, was 0.44. Meanwhile, the most recent TTM earnings summed to NA. From these numbers, we calculate the recent AQST PE on 4/25/2024 based on annualized quarterly EPS was 8.9. Based on AQST's history, that recent PE is elevated relative to the historical average, with the recent PE 178.1% higher than the historical average PE across our data set for Aquestive Therapeutics.

For self directed investors doing their due diligence on AQST or any other given stock, valuation analysis for AQST can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Aquestive Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for AQST. Thanks for visiting, and the next time you need to research AQST PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: Institutional Holders of ASBC, AJAX Options Chain, SNPR Options Chain.

 

AQST PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2024, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.